Answers are grounded in this paper and cite their sources.
Gene targeting in the mouse genome has generated a variety of mouse lines with complete deficiencies in virtually all know factors involved in haemostasis. In addition, transgenic techniques have produced mice with altered expression of some of these factors, which are required in cases of embryonic lethality. Based on these studies, in general, mouse haemostasis is very similar to haemostasis in humans, however, some differences do exist. In this theme issue of Thrombosis and Haemostasis several articles (see pages 444– 508) are published that summarize the generation of a wide variety of genetically modified mice and their analysis in haemostasis and thrombosis models. . . .
No takes yet. Share an insight, caveat, or question.
Nigel Mackman (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: